MicroCures Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $100K

  • Investors
  • 4

MicroCures General Information

Description

Developer of biopharmaceutical therapies designed to harness the body's innate cellular capacity to repair tissue, nerves, and organs. The company's therapeutic platform precisely controls the rate and direction of cell migration to enable cellular mechanisms within the body to accelerate and improve recovery after traumatic injury, enabling the health sector to deliver powerful therapeutic benefits for a variety of large and underserved medical applications.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 105 Sylvar Street
  • Santa Cruz, CA 95060-3728
  • United States
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • 105 Sylvar Street
  • Santa Cruz, CA 95060-3728
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MicroCures Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC 13-May-2021 $100K Completed Generating Revenue
4. Grant 28-Jan-2020 Completed Generating Revenue
3. Grant 01-Jan-2020 Completed Generating Revenue
2. Grant 15-Sep-2018 $942K $3M Completed Generating Revenue
1. Later Stage VC (Series A) 02-Apr-2018 $3M $3M Completed Generating Revenue
To view MicroCures’s complete valuation and funding history, request access »

MicroCures Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view MicroCures’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

MicroCures Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biopharmaceutical therapies designed to harness the body's innate cellular capacity to repair tissue, nerve
Biotechnology
Santa Cruz, CA
8 As of 2026

Malvern, PA
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MicroCures Competitors (76)

One of MicroCures’s 76 competitors is Progenra, a Formerly VC-backed company based in Malvern, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Progenra Formerly VC-backed Malvern, PA
Strand Therapeutics Venture Capital-Backed Boston, MA
Endeavor BioMedicines Venture Capital-Backed San Diego, CA
Centrose Venture Capital-Backed Madison, WI
TILT Biotherapeutics Venture Capital-Backed Helsinki, Finland
You’re viewing 5 of 76 competitors. Get the full list »

MicroCures Patents

MicroCures Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024381039-A1 Agents targeting fidgetin-like 2 and uses thereof Pending 16-Nov-2023
EP-4808566-A1 Agents targeting fidgetin-like 2 and uses thereof Pending 16-Nov-2023
WO-2025106876-A1 Agents targeting fidgetin-like 2 and uses thereof Inactive 16-Nov-2023
AU-2023375354-A1 Methods and agents for treating neurotrophic keratitis Pending 08-Nov-2022
EP-4622634-A1 Methods and agents for treating neurotrophic keratitis Pending 08-Nov-2022 A61K9/0048
To view MicroCures’s complete patent history, request access »

MicroCures Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MicroCures Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
United States Army Institute of Surgical Research Government
National Institutes of Health Government
U.S. Department of Health and Human Services Government
Mentors Fund Venture Capital Minority
To view MicroCures’s complete investors history, request access »

MicroCures FAQs

  • When was MicroCures founded?

    MicroCures was founded in 2011.

  • Where is MicroCures headquartered?

    MicroCures is headquartered in Santa Cruz, CA.

  • What is the size of MicroCures?

    MicroCures has 8 total employees.

  • What industry is MicroCures in?

    MicroCures’s primary industry is Biotechnology.

  • Is MicroCures a private or public company?

    MicroCures is a Private company.

  • What is MicroCures’s current revenue?

    The current revenue for MicroCures is .

  • How much funding has MicroCures raised over time?

    MicroCures has raised $3.1M.

  • Who are MicroCures’s investors?

    United States Army Institute of Surgical Research, National Institutes of Health, U.S. Department of Health and Human Services, and Mentors Fund have invested in MicroCures.

  • Who are MicroCures’s competitors?

    Progenra, Strand Therapeutics, Endeavor BioMedicines, Centrose, and TILT Biotherapeutics are some of the 76 competitors of MicroCures.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process